This discrepancy may be attributed to lower hCtr1 expression in prostate cancer compared to hepatoma, and the extended time required for tracer accumulation, which is influenced by a balance between tracer uptake via hCtr1 and washout via copper efflux pumps such as ATP7A and ATP7B. The gene discussed is SLC31A1; the disease is prostate carcinoma.